Managing Complex Coronary Revascularization of Acute Coronary Syndrome During Cogan Syndrome

Jacopo Giovacchini1, Francesco Cappelli2, Benedetta Tomberli3

  • 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

JACC. Case Reports
|March 7, 2025
PubMed

Insights

Cogan syndrome, an autoimmune vasculitis, can cause coronary artery issues and acute coronary syndrome. This case highlights the challenges of treating heart conditions in patients with active Cogan syndrome.

Area of Science:

  • Cardiology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Cogan syndrome is a rare multisystemic autoimmune vasculitis.
  • It can affect the cardiovascular system, leading to coronaritis.
  • Coronaritis is inflammation of the coronary arteries, potentially causing acute coronary syndrome.

Observation:

  • This paper details a case of a young woman with Cogan syndrome.
  • The patient presented with acute coronary syndrome.
  • The cause was identified as a left main coronary artery lesion.

Findings:

  • The case illustrates the complexities in managing acute coronary syndrome in the context of active vasculitis.
  • Treatment strategies for revascularization require careful consideration due to the underlying autoimmune condition.

Implications:

  • This case underscores the importance of recognizing cardiac manifestations of Cogan syndrome.
  • It emphasizes the need for tailored revascularization approaches in patients with active autoimmune vasculitis.
  • Further research may be needed to optimize treatment protocols for this rare condition.

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
433
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
34
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K